glp 1 for chronic kidney disease GLP-1s lower BMI, preserve function adults with diabetes post- kidney transplant SGLT2is, GLP-1RAs, and GIP/GLP-1RAs for

GLP-1 agonists may reshape the gut microbiome

A comprehensive 2017 meta-analysis of 17 randomized controlled trials involving over 1,600 patients with chronic heart failure confirmed that targeted L-carnitine treatment significantly improves left ventricular ejection fraction and overall cardiac output

To address this in an unbiased way, we profiled mitochondrial metabolites of SLC25A39 knockout cell lines and those complemented with SLC25A39 cDNA by LC-MS

Biocompatible glutathione-capped gold nanoclusters for dual fluorescent sensing and imaging of copper(II) and temperature in human cells and bacterial cells

For GLP-1s specifically, because they tend to have such an outsize impact on prescription spending, its a good idea to have a pharmacist assist in evaluating them